WithdrawnNot Applicable

Rapid Sequence Intubation Drug Delivery Using Intraosseous and IV Access in Pediatric Patients Observational Study

Stopped: No subject enrollment.

United States0Started 2012-09

Plain-language summary

This study will evaluate using intraosseous vascular access and intravenous vascular access to give pediatric patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * subjects requiring rapid sequence intubation for whom rocuronium is chosen as the paralytic agent. * the operator chooses to place a peripheral intravenous or powered intraosseous catheter to permit rapid sequence intubation. Exclusion Criteria: * subjects in whom vascular access for rapid sequence intubation drug administration was established prior to arrival to the emergency department.

What they're measuring

Time from determination of need for vascular access for rapid sequence intubation to administration of first does of paralytic agent.

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

Time from vascular access to intubation first attempt, as indicated by the first attempt to visualize the larynx with the laryngoscope.

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

time from vascular access to successful intubation

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

number of attempts necessary for successful intubation

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

Trial details

NCT IDNCT01634867

SponsorVidacare Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2014-08

View on ClinicalTrials.gov More Airway Control trials